At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Coroflex® ISAR Drug-eluting stent +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intra-patient Randomized Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT Follow up
Hospital Universitari Vall d'Hebron Research Institute·interventional·Posted May 27, 2016·Updated Jan 3, 2019
In Brief
A clinical study evaluating Coroflex® ISAR Drug-eluting stent and Ultimaster® Drug-eluting stent for Coronary Artery Disease. Completed, enrolled 70 participants across 3 sites.
Detailed Summary
The objective of the study is to evaluate the process of early re-endothelialization of the Coroflex® ISAR Drug-eluting stent compared with the Ultimaster® Drug-eluting stent
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesSpain
CollaboratorsB.Braun Surgical SA
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 2016
Enrollment StartJun 2016
Primary CompletionJan 2019
TodayJul 2026
First PostedMay 27, 2016
Enrollment StartJun 1, 2016
Primary CompletionJan 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 10.1 years ago
Interventions
Coroflex® ISAR Drug-eluting stentdevice
Coroflex® ISAR Drug-eluting stent and an Ultimaster® Drug-eluting stent in the second lesion.
Ultimaster® Drug-eluting stentdevice
Ultimaster® Drug-eluting stent and a Coroflex® ISAR Drug-eluting stent in the second lesion.